Edwin Fuentes
Family Medicine · Reidsville, NCNPI 1053360966
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $622 and has fallen 80.7% since, to $120 in 2025.
Across 58 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$140
- AstraZeneca$70
- Neurocrine Biosciences, Inc.$66
- Lundbeck LLC$66
- Argenx US, Inc.$61
- SK Life Science, Inc.$58
- plus $702 from 24 others
What the payments were for
- Food & beverage$1,164100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $140 |
| AstraZeneca | 3 | $70 |
| Neurocrine Biosciences, Inc. | 3 | $66 |
| Lundbeck LLC | 4 | $66 |
| Argenx US, Inc. | 3 | $61 |
| SK Life Science, Inc. | 3 | $58 |
| AbbVie | 3 | $56 |
| Eisai Inc. | 3 | $52 |
| Merck | 3 | $52 |
| Amgen | 3 | $50 |
| Boston Scientific | 2 | $45 |
| UCB, Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Impel Pharmaceuticals Inc. | 2 | $36 |
| Acadia Pharmaceuticals Inc | 2 | $34 |
| Neurelis, Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
| EMD Serono, Inc. | 2 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Sanofi | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Adamas Pharmaceuticals, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Banner Life Sciences, LLC | 1 | $16 |
| Corium, LLC | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Aprecia Pharmaceuticals, LLC | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$120
How this compares
$1,164 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Reidsville
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
- Christopher ChaoCary$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.